Craig Taylor has been named 2022 Veteran Entrepreneur of the Year by the Rice Business Veterans Association and has made it to the finals for EY's Entrepreneur Of The Year 2022. Photo courtesy of Iapetus

Houston’s Craig Taylor is basking in the entrepreneurial spotlight.

On May 10, Taylor, founder and CEO of Houston-based Iapetus Holdings, and Tejpal Singh, co-founder and chief operating officer, were named Entrepreneur Of The Year 2022 finalists in the program’s Central South region. That region includes the Houston area. Professional services giant Ernest & Young sponsors the program.

Meanwhile, Taylor last month was named 2022 Veteran Entrepreneur of the Year by the Rice Business Veterans Association at Rice University’s Jones Graduate School of Business.

Iapetus Holdings is a minority- and veteran-owned portfolio of eight self-funded, multimillion-dollar companies in the energy sector.

“When you set off to become a self-funded entrepreneur, you start with a vision and a ton of grit, but you never really have assurance of the fact that you’re going to be successful,” Taylor says in a news release. “The road to business success takes many turns and that’s why, to find ourselves among those honored with this distinction, to be among the EY Entrepreneur of the Year finalists, is so meaningful.”

Singh says he and Taylor “have much greater ambitions” for Iapetus as well as Atlas Scholars, the nonprofit they launched to provide internships and scholarships to high school students.

“It has taken a ton of dedication and effort to realize our ambition of building this group of energy solutions businesses, creating this number of jobs, serving this quantity and quality of clients,” Singh says.

Regional Entrepreneur Of The Year winners will be announced June 23.

The Entrepreneur Of The Year nod follows Taylor’s acceptance April 23 of Rice’s Veteran Entrepreneur of the Year honor.

Navy veteran Charles “Reid” Schrodel, an officer with Rice Business Veterans Association, says Taylor was chosen for the honor because of his success in business and philanthropy.

“For the Veteran Entrepreneur of the Year award, “we were looking for veteran entrepreneurs that are successful in their field, and we wanted to find a vet entrepreneur whose organization also gave back to their communities,” Schrodel says.

Taylor received the award during the Rice Veterans Business Battle competition. He and Alex Danielides, head of business development at Iapetus Holdings, were judges for the competition. In the competition, 16 early stage companies vied for funding. The 2022 winners were Libre, Opera Bioscience, and Bonappesweet.

In a news release, Taylor notes that veterans who own businesses face an array of challenges.

“Being an entrepreneur is not easy, but the Navy instilled in me a strong sense of responsibility and grit, which are critical characteristics of a successful entrepreneur,” he says.

Businesses under the Iapetus umbrella are:

  • Atlas Commodities, a commodity brokerage firm.
  • Atlas Field Services, which provides safety inspections and audits for energy providers.
  • Atlas Retail Energy, a provider of energy management services for commercial and industrial customers.
  • Gold Coast Utility Specialists, which provides risk management services for energy suppliers.
  • Hyperion Safety Environmental Solutions, whose services include safety programming and environmental planning.
  • Iapetus Infrastructure Services, which encompasses five of the holding company’s eight subsidiaries.
  • Soaring Eagle Technologies, a provider of mapping services.
  • UATI (Unmanned Aviation Training Institute), which trains drone operators.

Collectively, annual revenue for the eight subsidiaries is around $100 million.

“Our customers rely on Iapetus employees who are innovating and are making a difference on the most critical issues of our times. We’re affecting everything from energy security to sustainability to infrastructure reliability, and we do so as a cohesive group of diverse perspectives working toward common goals,” Taylor said in a 2021 news release.

“Our companies are working closely with utilities on strategies to help prevent risks, plan vegetation management, keep the lights on and employees safe,” he added. “We’re also helping commercial and industrial clients procure energy efficiently and sustainably, while providing international energy trade brokerage services in this intense-demand landscape.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”